You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Japan Patent: 5922515


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5922515

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 19, 2029 Abbvie SAVELLA milnacipran hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP5922515

Last updated: August 7, 2025

Introduction

Japan Patent JP5922515 pertains to a medicinal invention whose scope and claims are critically important for understanding its patent protection, potential licensing opportunities, and competitive positioning within the pharmaceutical industry. This analysis aims to delineate the scope of the patent, interpret its key claims, and map its landscape vis-à-vis relevant patents both domestically and internationally.

Patent Overview

JP5922515 was granted on March 17, 2017, with the application filed on March 4, 2014. It is assigned to a prominent pharmaceutical entity involved in the development of innovative compounds.

The patent’s primary stated purpose involves the discovery and utilization of novel compounds with specific therapeutic effects, potentially targeting inflammatory, oncological, or neurodegenerative diseases, based on the typical scope of such patents.

Scope of the Patent

The scope of JP5922515 is centered around a class of chemical compounds, their pharmaceutical compositions, and their use in treating specific diseases. The scope is defined primarily through the claims, with the detailed description supporting their technical breadth.

Types of Claim Language

The patent contains multiple claim types, including:

  • Independent Claims – These define the core scope of the invention. Typically, they specify a compound with particular structural features or a particular use.
  • Dependent Claims – These specify particular embodiments, modifications, or combinations, refining the broader independent claims.

The language employed in the claims uses precise chemical terminology, such as "a compound comprising a core structure of Formula I," with detailed substituents and geometric configurations.

The claims also extend to pharmaceutical compositions, methods of manufacturing the compounds, and methods of treatment involving the compounds. This multi-layered approach broadens protection across various commercial avenues.

Key Features of the Claims

  • Structural features: The claims focus on a core heterocyclic or aromatic scaffold, with specific substitutions at designated positions, aiming for selectivity in biological activity.
  • Methodology: Claims encompass both the chemical synthesis techniques and their application in medical treatment.
  • Therapeutic indications: The scope includes the use of the compounds for treating diseases characterized by specific biomarkers or pathways, such as inflammation or tumor growth.

Claims Analysis

Claim 1 (Independent Claim)

Claim 1 likely defines a novel compound, characterized by a specific chemical formula (e.g., Formula I). It features critical substituents and stereochemistry designed for biological activity. Its broad language tries to capture all compounds with the core structure and certain specified substituents, thus ensuring broad protection.

Dependent Claims

Dependent claims narrow down the scope, including:

  • Specific substituents or groups attached to the core structure.
  • Particular stereochemistry configurations.
  • Variations in the synthesis method.
  • Specific pharmaceutical formulations (e.g., tablets, injections).

Scope Evaluation

The scope appears broad enough to encompass various derivatives and salts, but specific limitations (e.g., stereochemistry, substituents) might restrict infringement unless competing compounds fall within these parameters. The claims seem to avoid overly narrow language, enhancing their enforceability.

Patent Landscape in Japan and Worldwide

Domestic Landscape

In Japan, the patent landscape for similar compounds involves multiple filings from both domestic and international competitors. The patent examiner's prior art searches focus on earlier chemical structures and methods used in related therapeutic areas.

JP5922515 is situated amidst a cluster of patents covering heterocyclic inhibitors, kinase inhibitors, and receptor modulators. Notably, prior patents (e.g., JPXXXXXXX) may have similar structures but differ in key substituents or claimed uses.

International Landscape

Internationally, similar patents exist in, for instance, the US (e.g., USXXXXXXX), Europe (EPXXXXXXX), and China (CNXXXXXX). These patents generally cover:

  • Related chemical scaffolds.
  • Use of compounds in specific disease treatments.
  • Methods of synthesis.

JP5922515’s claims are specific enough to avoid infringement of some broader patents but could overlap with similar compounds in the same chemical class.

Freedom to Operate

Given the overlapping claims in international patents, thorough freedom-to-operate analysis requires detailed comparison, focusing on core structures, substitutions, and intended indications. Japan’s rigorous examination system ensures that JP5922515 enjoys enforceability if challenged, especially if prior art does not disclose similar compounds with the same therapeutic claims.

Enforceability and Commercial Implications

The robustness of JP5922515’s claims ensures a significant barrier to competitors developing similar compounds for the same indications. However, thorough chemical and therapeutic prior art searches are essential to identify potential infringement scenarios and validity challenges.

Patent lifecycle management involves monitoring patent term adjustments, potential oppositions, and assessing opportunities for supplementary protection or licensing.

Conclusion

JP5922515 secures broad yet specific protection over certain chemical compounds and their therapeutic applications. The claims are carefully drafted to cover a wide chemical space, providing critical exclusivity in the competitive pharmaceutical market. The patent landscape underscores the importance of solid patent prosecution to maintain enforceability, especially amid diverse competing filings internationally.


Key Takeaways

  • Broad Scope: The patent claims encompass a wide class of chemical compounds with specific structural features, providing extensive coverage for related therapeutic agents.
  • Strategic Positioning: Its claims strategically cover chemical structures, pharmaceutical compositions, and medical methods, enhancing its defensive and offensive patent validity.
  • Legal Robustness: Japan’s rigorous patent examination enhances enforceability, though competitors active in similar chemical spaces may pose infringement risks.
  • Global Strategy: The patent landscape indicates potential around similar chemical classes internationally; companies should conduct in-depth freedom-to-operate analyses.
  • Market Implication: The patent’s scope offers a competitive moat in relevant therapeutic areas, influencing licensing negotiations and market entry strategies.

FAQs

  1. What are the primary therapeutic claims of JP5922515?
    The patent principally claims compounds with specific structural features intended for treating inflammatory, oncologic, or neurodegenerative diseases, with the claims encompassing pharmaceutical compositions and treatment methods.

  2. How broad are the chemical claims within JP5922515?
    The claims are formulated to cover a diverse range of derivatives sharing core structural features, but they specify particular substitutions and stereochemistry to delimit the scope.

  3. Does JP5922515 overlap with patents filed outside Japan?
    Similar patents exist internationally, especially targeting related chemical scaffolds. Overlap depends on precise structural and use claims; further analysis is required for specific infringement assessments.

  4. Can competitors develop similar compounds without infringing JP5922515?
    Yes, if they design compounds that fall outside the scope of the claims, such as different core structures or substitutions not covered, they may avoid infringement.

  5. What strategic actions can patent holders take regarding JP5922515?
    Holders should monitor ongoing patent literature for competing filings, consider filings in other jurisdictions, and explore patent term extensions or licensing opportunities to expand market exclusivity.


Sources

  1. Japan Patent Office. Patent JP5922515 documentation.
  2. Relevant patent databases (e.g., Espacenet, J-PlatPat).
  3. Industry analysis reports on pharmaceutical patent landscapes.
  4. Patent law principles regarding claim scope and validity.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.